Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075268 | SCV001240883 | likely pathogenic | Retinal dystrophy | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002557924 | SCV003523481 | pathogenic | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 866897). This premature translational stop signal has been observed in individual(s) with Usher syndrome type II (PMID: 26338283). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg4137Glufs*30) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV003455410 | SCV004182002 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing |